Skip to main content

Stokes Capital Advisors, LLC

Position in NVO — Novo Nordisk A S

CIK 1734460 GREENWOOD, SC

Position in NVO

as of Jun 30, 2026 · filed Jul 22, 2026
Position Value
$412,284
+$96,234 QoQ
Shares Held
8,600
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#777
of 1,348 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Stokes Capital Advisors, LLC holds $39,481,428 across 8 Drug Manufacturers - General names. NVO ranks #8 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 NVO
Novo Nordisk A S
This page
8,600 $412,284

All Filings in NVO

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $412,284 8,600
2026-03-31 $316,050 8,600
2025-12-31 $482,596 9,485
2025-09-30 $868,973 15,660
2025-06-30 $4,812,695 69,729
2025-03-31 $4,347,082 62,602
2024-12-31 $1,174,603 13,655
2024-09-30 $1,516,356 12,735
2024-06-30 $1,824,930 12,785
2024-03-31 $1,435,512 11,180
2023-12-31 $1,187,606 11,480
2023-09-30 $1,043,991 11,480
2023-06-30 $928,904 5,740
2023-03-31 $913,463 5,740
2022-12-31 $997,455 7,370
2022-09-30 $734,273 7,370
2022-06-30 $821,239 7,370
2022-03-31 $818,438 7,370
2021-12-31 $825,440 7,370
2021-09-30 $707,593 7,370
2021-06-30 $617,384 7,370